Synthetic Biology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies), By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism), By End user (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others), By Region and Competition, 2019-2029F
Global Synthetic Biology Market was valued at USD 11.52 Billion in 2023 and is anticipated t%li%project steady growth in the forecast period with a CAGR of 5.25% through 2029. Synthetic biology, an interdisciplinary field that merges biology and engineering principles t%li%design and construct new biological parts, devices, and systems, is rapidly gaining momentum across various industries. With advancements in genetic engineering, DNA sequencing technologies, and computational modeling, the global synthetic biology market is experiencing exponential growth, revolutionizing industries ranging from healthcare and agriculture t%li%energy and manufacturing. Breakthroughs in gene editing technologies such as CRISPR-Cas9 have empowered scientists t%li%manipulate DNA with unprecedented precision, facilitating the creation of custom-designed organisms for various purposes.
Key Market Drivers
Increasing Demand for Bio-Based Products is Driving the Global Synthetic Biology Market
In recent years, there has been a notable surge in the demand for bio-based products across various industries worldwide. This burgeoning trend is propelled by a growing awareness of sustainability, environmental concerns, and the need for innovative solutions t%li%address pressing global challenges. At the forefront of this transformative movement is the field of synthetic biology, which offers promising opportunities for the development of novel bio-based products. As a result, the global synthetic biology market is experiencing remarkable growth, driven by the escalating demand for sustainable alternatives t%li%conventional products. With growing concerns about climate change, resource depletion, and pollution, there is a pressing need t%li%transition towards more sustainable practices. Bio-based products derived from renewable sources offer a viable alternative t%li%fossil fuels and petrochemical-based products, reducing greenhouse gas emissions and environmental footprint.
Consumers are becoming more conscious of the environmental and health impacts of the products they use. There is a rising demand for eco-friendly and non-toxic alternatives across various sectors, including cosmetics, personal care, food, and packaging. Synthetic biology enables the production of biodegradable materials, natural flavors, fragrances, and sustainable ingredients, catering t%li%evolving consumer preferences. Governments and regulatory agencies are increasingly supporting the development and commercialization of bio-based products through policies, grants, and incentives. Initiatives aimed at promoting renewable energy, reducing carbon emissions, and fostering innovation in biotechnology are driving investments in synthetic biology research and development. Advances in gene editing techniques, DNA synthesis, and automation are accelerating the pace of innovation in synthetic biology. The emergence of high-throughput screening methods, bioinformatics tools, and computational Modeling enables researchers t%li%design and optimize biological systems with greater precision and efficiency. These technological breakthroughs are unlocking new possibilities for the customization and scale-up of bio-based production processes.
Expanding Applications in Healthcare is Driving the Global Synthetic Biology Market
Synthetic biology, a burgeoning field at the intersection of biology, engineering, and computational science, is revolutionizing the healthcare sector with its innovative applications. This multidisciplinary approach enables scientists t%li%engineer biological systems for diverse purposes, ranging from drug discovery and development t%li%personalized medicine and biomanufacturing. The global synthetic biology market is witnessing significant growth, fueled by expanding applications in healthcare and advancements in genetic engineering technologies. The healthcare industry is experiencing a paradigm shift with the integration of synthetic biology. One of the primary drivers of this transformation is the ability t%li%engineer biological systems t%li%produce valuable therapeutics. Synthetic biology enables the design and synthesis of novel molecules, including proteins, enzymes, and small molecules, for the treatment of various diseases.
Synthetic biology offers unprecedented opportunities for accelerating drug discovery and development processes. By leveraging techniques such as gene editing, pathway engineering, and metabolic engineering, researchers can design and optimize biological systems t%li%produce pharmaceutical compounds with enhanced efficacy and safety profiles. This approach not only expedites the drug development timeline but als%li%facilitates the creation of targeted therapies for complex diseases, such as cancer and genetic disorders. Advancements in synthetic biology are paving the way for personalized medicine, wherein treatments are tailored t%li%individual patients based on their genetic makeup and specific health conditions. Through genome editing technologies like CRISPR-Cas9, scientists can precisely modify DNA sequences associated with disease susceptibility or drug response, enabling the development of customized therapeutic interventions. This personalized approach holds immense potential for improving patient outcomes and minimizing adverse reactions t%li%medications. Synthetic biology is revolutionizing the biomanufacturing sector by offering sustainable and cost-effective alternatives t%li%traditional production methods. Engineered microorganisms, such as bacteria and yeast, serve as cellular factories for the synthesis of pharmaceuticals, biofuels, and industrial chemicals. By optimizing metabolic pathways and genetic circuits, researchers can enhance microbial productivity, streamline production processes, and reduce environmental impact. This transformative approach is driving the development of bio-based manufacturing platforms that promise t%li%revolutionize various industries.
Key Market Challenges
Regulatory Complexity
One of the primary challenges confronting the synthetic biology market is the intricate regulatory landscape. Given the novel nature of synthetic organisms and genetic engineering techniques, regulatory agencies worldwide are tasked with ensuring safety, ethical considerations, and environmental impact assessments. Navigating this complex regulatory framework often requires significant time and resources, posing a barrier t%li%market entry for startups and small enterprises.
Ethical and Societal Concerns
The manipulation of genetic material and the creation of synthetic organisms raise ethical and societal questions regarding the potential consequences of unintended environmental release, biosecurity risks, and equitable access t%li%biotechnological advancements. Public perception and acceptance of synthetic biology applications play a crucial role in shaping regulatory policies and market dynamics. Addressing these concerns necessitates transparent communication, robust ethical frameworks, and engagement with stakeholders across diverse sectors.
Key Market Trends
Technological Advancements
In the ever-evolving landscape of biotechnology, one field stands out for its revolutionary potential – synthetic biology. Harnessing the power of molecular biology, engineering principles, and computational techniques, synthetic biology aims t%li%redesign and construct biological components, systems, and organisms with novel functionalities. As technological advancements continue t%li%accelerate, the global synthetic biology market is experiencing unprecedented growth, fueled by innovation and demand across various sectors. The rapid progression of technologies such as CRISPR-Cas9 gene editing, next-generation sequencing, and high-throughput DNA synthesis has propelled synthetic biology int%li%the forefront of scientific and industrial innovation. These advancements have significantly reduced the cost and time required for genetic manipulation, enabling researchers t%li%engineer biological systems with unprecedented precision and scale.
CRISPR-Cas9, in particular, has revolutionized the field by offering a highly efficient and versatile tool for genome editing. Its applications span from basic research t%li%therapeutic development, agricultural improvement, and industrial biomanufacturing. The ability t%li%precisely edit DNA sequences has opened up new avenues for addressing complex challenges in healthcare, agriculture, and environmental sustainability.
Furthermore, advancements in DNA synthesis technologies have facilitated the rapid assembly of genetic constructs, allowing researchers t%li%design and test novel biological circuits and pathways with ease. High-throughput synthesis platforms have democratized access t%li%custom DNA sequences, empowering scientists and entrepreneurs t%li%explore diverse applications of synthetic biology across industries.
Segmental Insights
Product Insights
Based on the category of Product, Oligonucleotide/Olig%li%Pools and Synthetic DNA emerged as the dominant segment in the global market for Synthetic Biology in 2023. Oligonucleotide/olig%li%pools and synthetic DNA serve as the building blocks of synthetic biology. These technologies enable researchers t%li%design, modify, and synthesize DNA sequences with precision and efficiency previously unimaginable. Olig%li%pools consist of a collection of short, single-stranded DNA or RNA molecules that can be customized t%li%contain specific sequences of interest. Synthetic DNA, on the other hand, involves the laboratory synthesis of entire genes or genomes. Olig%li%pools and synthetic DNA offer unparalleled customization and flexibility, allowing researchers t%li%tailor DNA sequences t%li%meet their exact specifications. This level of control is crucial for designing biological systems with desired functionalities, such as gene editing, protein expression, and pathway optimization. Olig%li%pools and synthetic DNA find applications across a wide range of industries, including healthcare, agriculture, energy, and environmental remediation. From engineering microbial strains for biofuel production t%li%designing personalized therapeutics for precision medicine, the potential applications of these technologies are virtually limitless.
Technology Insights
The PCR Technology segment is projected t%li%experience rapid growth during the forecast period. The global synthetic biology market has experienced exponential growth in recent years, with PCR technology playing a vital role in driving this expansion. PCR-based techniques are extensively used in synthetic biology research, enabling scientists t%li%construct, modify, and analyze DNA sequences with unparalleled accuracy. This has led t%li%the development of novel bio-based products, therapeutic solutions, and sustainable technologies, driving the market forward. One of the key reasons for PCR's dominance in the synthetic biology market is its versatility and flexibility. PCR can be adapted t%li%various applications, including gene synthesis, DNA assembly, and site-directed mutagenesis, making it an indispensable tool for researchers across different disciplines. Additionally, advancements in PCR technology, such as real-time PCR and digital PCR, have further expanded its utility, allowing for precise quantification and analysis of DNA sequences.
Regional Insights
North America boasts a robust ecosystem of research institutions, universities, and biotechnology companies dedicated t%li%advancing synthetic biology. Leading academic institutions such as MIT, Harvard, and Stanford have established renowned research programs and interdisciplinary collaborations in synthetic biology. Additionally, the region is home t%li%prominent biotech hubs like the San Francisc%li%Bay Area, Boston-Cambridge corridor, and San Diego, fostering innovation and entrepreneurship in the field.
In this report, the Global Synthetic Biology Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Synthetic Biology Market.
Available Customizations:
Global Synthetic Biology market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Demand for Bio-Based Products is Driving the Global Synthetic Biology Market
In recent years, there has been a notable surge in the demand for bio-based products across various industries worldwide. This burgeoning trend is propelled by a growing awareness of sustainability, environmental concerns, and the need for innovative solutions t%li%address pressing global challenges. At the forefront of this transformative movement is the field of synthetic biology, which offers promising opportunities for the development of novel bio-based products. As a result, the global synthetic biology market is experiencing remarkable growth, driven by the escalating demand for sustainable alternatives t%li%conventional products. With growing concerns about climate change, resource depletion, and pollution, there is a pressing need t%li%transition towards more sustainable practices. Bio-based products derived from renewable sources offer a viable alternative t%li%fossil fuels and petrochemical-based products, reducing greenhouse gas emissions and environmental footprint.
Consumers are becoming more conscious of the environmental and health impacts of the products they use. There is a rising demand for eco-friendly and non-toxic alternatives across various sectors, including cosmetics, personal care, food, and packaging. Synthetic biology enables the production of biodegradable materials, natural flavors, fragrances, and sustainable ingredients, catering t%li%evolving consumer preferences. Governments and regulatory agencies are increasingly supporting the development and commercialization of bio-based products through policies, grants, and incentives. Initiatives aimed at promoting renewable energy, reducing carbon emissions, and fostering innovation in biotechnology are driving investments in synthetic biology research and development. Advances in gene editing techniques, DNA synthesis, and automation are accelerating the pace of innovation in synthetic biology. The emergence of high-throughput screening methods, bioinformatics tools, and computational Modeling enables researchers t%li%design and optimize biological systems with greater precision and efficiency. These technological breakthroughs are unlocking new possibilities for the customization and scale-up of bio-based production processes.
Expanding Applications in Healthcare is Driving the Global Synthetic Biology Market
Synthetic biology, a burgeoning field at the intersection of biology, engineering, and computational science, is revolutionizing the healthcare sector with its innovative applications. This multidisciplinary approach enables scientists t%li%engineer biological systems for diverse purposes, ranging from drug discovery and development t%li%personalized medicine and biomanufacturing. The global synthetic biology market is witnessing significant growth, fueled by expanding applications in healthcare and advancements in genetic engineering technologies. The healthcare industry is experiencing a paradigm shift with the integration of synthetic biology. One of the primary drivers of this transformation is the ability t%li%engineer biological systems t%li%produce valuable therapeutics. Synthetic biology enables the design and synthesis of novel molecules, including proteins, enzymes, and small molecules, for the treatment of various diseases.
Synthetic biology offers unprecedented opportunities for accelerating drug discovery and development processes. By leveraging techniques such as gene editing, pathway engineering, and metabolic engineering, researchers can design and optimize biological systems t%li%produce pharmaceutical compounds with enhanced efficacy and safety profiles. This approach not only expedites the drug development timeline but als%li%facilitates the creation of targeted therapies for complex diseases, such as cancer and genetic disorders. Advancements in synthetic biology are paving the way for personalized medicine, wherein treatments are tailored t%li%individual patients based on their genetic makeup and specific health conditions. Through genome editing technologies like CRISPR-Cas9, scientists can precisely modify DNA sequences associated with disease susceptibility or drug response, enabling the development of customized therapeutic interventions. This personalized approach holds immense potential for improving patient outcomes and minimizing adverse reactions t%li%medications. Synthetic biology is revolutionizing the biomanufacturing sector by offering sustainable and cost-effective alternatives t%li%traditional production methods. Engineered microorganisms, such as bacteria and yeast, serve as cellular factories for the synthesis of pharmaceuticals, biofuels, and industrial chemicals. By optimizing metabolic pathways and genetic circuits, researchers can enhance microbial productivity, streamline production processes, and reduce environmental impact. This transformative approach is driving the development of bio-based manufacturing platforms that promise t%li%revolutionize various industries.
Key Market Challenges
Regulatory Complexity
One of the primary challenges confronting the synthetic biology market is the intricate regulatory landscape. Given the novel nature of synthetic organisms and genetic engineering techniques, regulatory agencies worldwide are tasked with ensuring safety, ethical considerations, and environmental impact assessments. Navigating this complex regulatory framework often requires significant time and resources, posing a barrier t%li%market entry for startups and small enterprises.
Ethical and Societal Concerns
The manipulation of genetic material and the creation of synthetic organisms raise ethical and societal questions regarding the potential consequences of unintended environmental release, biosecurity risks, and equitable access t%li%biotechnological advancements. Public perception and acceptance of synthetic biology applications play a crucial role in shaping regulatory policies and market dynamics. Addressing these concerns necessitates transparent communication, robust ethical frameworks, and engagement with stakeholders across diverse sectors.
Key Market Trends
Technological Advancements
In the ever-evolving landscape of biotechnology, one field stands out for its revolutionary potential – synthetic biology. Harnessing the power of molecular biology, engineering principles, and computational techniques, synthetic biology aims t%li%redesign and construct biological components, systems, and organisms with novel functionalities. As technological advancements continue t%li%accelerate, the global synthetic biology market is experiencing unprecedented growth, fueled by innovation and demand across various sectors. The rapid progression of technologies such as CRISPR-Cas9 gene editing, next-generation sequencing, and high-throughput DNA synthesis has propelled synthetic biology int%li%the forefront of scientific and industrial innovation. These advancements have significantly reduced the cost and time required for genetic manipulation, enabling researchers t%li%engineer biological systems with unprecedented precision and scale.
CRISPR-Cas9, in particular, has revolutionized the field by offering a highly efficient and versatile tool for genome editing. Its applications span from basic research t%li%therapeutic development, agricultural improvement, and industrial biomanufacturing. The ability t%li%precisely edit DNA sequences has opened up new avenues for addressing complex challenges in healthcare, agriculture, and environmental sustainability.
Furthermore, advancements in DNA synthesis technologies have facilitated the rapid assembly of genetic constructs, allowing researchers t%li%design and test novel biological circuits and pathways with ease. High-throughput synthesis platforms have democratized access t%li%custom DNA sequences, empowering scientists and entrepreneurs t%li%explore diverse applications of synthetic biology across industries.
Segmental Insights
Product Insights
Based on the category of Product, Oligonucleotide/Olig%li%Pools and Synthetic DNA emerged as the dominant segment in the global market for Synthetic Biology in 2023. Oligonucleotide/olig%li%pools and synthetic DNA serve as the building blocks of synthetic biology. These technologies enable researchers t%li%design, modify, and synthesize DNA sequences with precision and efficiency previously unimaginable. Olig%li%pools consist of a collection of short, single-stranded DNA or RNA molecules that can be customized t%li%contain specific sequences of interest. Synthetic DNA, on the other hand, involves the laboratory synthesis of entire genes or genomes. Olig%li%pools and synthetic DNA offer unparalleled customization and flexibility, allowing researchers t%li%tailor DNA sequences t%li%meet their exact specifications. This level of control is crucial for designing biological systems with desired functionalities, such as gene editing, protein expression, and pathway optimization. Olig%li%pools and synthetic DNA find applications across a wide range of industries, including healthcare, agriculture, energy, and environmental remediation. From engineering microbial strains for biofuel production t%li%designing personalized therapeutics for precision medicine, the potential applications of these technologies are virtually limitless.
Technology Insights
The PCR Technology segment is projected t%li%experience rapid growth during the forecast period. The global synthetic biology market has experienced exponential growth in recent years, with PCR technology playing a vital role in driving this expansion. PCR-based techniques are extensively used in synthetic biology research, enabling scientists t%li%construct, modify, and analyze DNA sequences with unparalleled accuracy. This has led t%li%the development of novel bio-based products, therapeutic solutions, and sustainable technologies, driving the market forward. One of the key reasons for PCR's dominance in the synthetic biology market is its versatility and flexibility. PCR can be adapted t%li%various applications, including gene synthesis, DNA assembly, and site-directed mutagenesis, making it an indispensable tool for researchers across different disciplines. Additionally, advancements in PCR technology, such as real-time PCR and digital PCR, have further expanded its utility, allowing for precise quantification and analysis of DNA sequences.
Regional Insights
North America boasts a robust ecosystem of research institutions, universities, and biotechnology companies dedicated t%li%advancing synthetic biology. Leading academic institutions such as MIT, Harvard, and Stanford have established renowned research programs and interdisciplinary collaborations in synthetic biology. Additionally, the region is home t%li%prominent biotech hubs like the San Francisc%li%Bay Area, Boston-Cambridge corridor, and San Diego, fostering innovation and entrepreneurship in the field.
- negative production of biofuels and biochemicals through innovative biosystems design.
- Bota Biosciences Inc.
- Codexis, Inc.
- Enbiotix, Inc.
- Illumina, Inc.
- Merck Kgaa (Sigma-Aldrich Co. Llc)
- Paret%li%Bio, Inc.
- Scarab Genomics, Llc
- Syntheg%li%Corporation
- Synthetic Genomics Inc.
- Therm%li%Fisher Scientific, Inc.
In this report, the Global Synthetic Biology Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Synthetic Biology Market, By Technology:
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
- Synthetic Biology Market, By Product:
- Oligonucleotide/Olig%li%Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
- Synthetic Biology Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Others
- Synthetic Biology Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Synthetic Biology Market.
Available Customizations:
Global Synthetic Biology market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. GLOBAL SYNTHETIC BIOLOGY MARKET OUTLOOK
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies)
4.2.2. By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism)
4.2.3. By End user (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others)
4.2.4. By Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Product
4.3.3. By End user
4.3.4. By Region
5. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Product
5.2.3. By End user
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Synthetic Biology Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Product
5.3.1.2.3. By End user
5.3.2. India Synthetic Biology Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Product
5.3.2.2.3. By End user
5.3.3. Australia Synthetic Biology Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Product
5.3.3.2.3. By End user
5.3.4. Japan Synthetic Biology Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Product
5.3.4.2.3. By End user
5.3.5. South Korea Synthetic Biology Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Product
5.3.5.2.3. By End user
6. EUROPE SYNTHETIC BIOLOGY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By End user
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Synthetic Biology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Product
6.3.1.2.3. By End user
6.3.2. Germany Synthetic Biology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Product
6.3.2.2.3. By End user
6.3.3. Spain Synthetic Biology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Product
6.3.3.2.3. By End user
6.3.4. Italy Synthetic Biology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Product
6.3.4.2.3. By End user
6.3.5. United Kingdom Synthetic Biology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Product
6.3.5.2.3. By End user
7. NORTH AMERICA SYNTHETIC BIOLOGY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By End user
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Synthetic Biology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Product
7.3.1.2.3. By End user
7.3.2. Mexico Synthetic Biology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Product
7.3.2.2.3. By End user
7.3.3. Canada Synthetic Biology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Product
7.3.3.2.3. By End user
8. SOUTH AMERICA SYNTHETIC BIOLOGY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By End user
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Synthetic Biology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Product
8.3.1.2.3. By End user
8.3.2. Argentina Synthetic Biology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Product
8.3.2.2.3. By End user
8.3.3. Colombia Synthetic Biology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Product
8.3.3.2.3. By End user
9. MIDDLE EAST AND AFRICA SYNTHETIC BIOLOGY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By End user
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Synthetic Biology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Product
9.3.1.2.3. By End user
9.3.2. Saudi Arabia Synthetic Biology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Product
9.3.2.2.3. By End user
9.3.3. UAE Synthetic Biology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Product
9.3.3.2.3. By End user
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. GLOBAL SYNTHETIC BIOLOGY MARKET: SWOT ANALYSIS
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. COMPETITIVE LANDSCAPE
14.1. Bota Biosciences Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Codexis, Inc.
14.3. Enbiotix, Inc.
14.4. Illumina, Inc.
14.5. Merck Kgaa (Sigma-Aldrich Co. Llc)
14.6. Pareto Bio, Inc.
14.7. Scarab Genomics, Llc
14.8. Synthego Corporation
14.9. Synthetic Genomics Inc.
14.10. Thermo Fisher Scientific, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. GLOBAL SYNTHETIC BIOLOGY MARKET OUTLOOK
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies)
4.2.2. By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism)
4.2.3. By End user (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others)
4.2.4. By Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Product
4.3.3. By End user
4.3.4. By Region
5. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Product
5.2.3. By End user
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Synthetic Biology Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Product
5.3.1.2.3. By End user
5.3.2. India Synthetic Biology Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Product
5.3.2.2.3. By End user
5.3.3. Australia Synthetic Biology Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Product
5.3.3.2.3. By End user
5.3.4. Japan Synthetic Biology Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Product
5.3.4.2.3. By End user
5.3.5. South Korea Synthetic Biology Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Product
5.3.5.2.3. By End user
6. EUROPE SYNTHETIC BIOLOGY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By End user
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Synthetic Biology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Product
6.3.1.2.3. By End user
6.3.2. Germany Synthetic Biology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Product
6.3.2.2.3. By End user
6.3.3. Spain Synthetic Biology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Product
6.3.3.2.3. By End user
6.3.4. Italy Synthetic Biology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Product
6.3.4.2.3. By End user
6.3.5. United Kingdom Synthetic Biology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Product
6.3.5.2.3. By End user
7. NORTH AMERICA SYNTHETIC BIOLOGY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By End user
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Synthetic Biology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Product
7.3.1.2.3. By End user
7.3.2. Mexico Synthetic Biology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Product
7.3.2.2.3. By End user
7.3.3. Canada Synthetic Biology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Product
7.3.3.2.3. By End user
8. SOUTH AMERICA SYNTHETIC BIOLOGY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By End user
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Synthetic Biology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Product
8.3.1.2.3. By End user
8.3.2. Argentina Synthetic Biology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Product
8.3.2.2.3. By End user
8.3.3. Colombia Synthetic Biology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Product
8.3.3.2.3. By End user
9. MIDDLE EAST AND AFRICA SYNTHETIC BIOLOGY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By End user
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Synthetic Biology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Product
9.3.1.2.3. By End user
9.3.2. Saudi Arabia Synthetic Biology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Product
9.3.2.2.3. By End user
9.3.3. UAE Synthetic Biology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Product
9.3.3.2.3. By End user
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. GLOBAL SYNTHETIC BIOLOGY MARKET: SWOT ANALYSIS
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. COMPETITIVE LANDSCAPE
14.1. Bota Biosciences Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Codexis, Inc.
14.3. Enbiotix, Inc.
14.4. Illumina, Inc.
14.5. Merck Kgaa (Sigma-Aldrich Co. Llc)
14.6. Pareto Bio, Inc.
14.7. Scarab Genomics, Llc
14.8. Synthego Corporation
14.9. Synthetic Genomics Inc.
14.10. Thermo Fisher Scientific, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
